Man Group’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Man Group’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-11,025	Closed	-$13K	–	2315
2022 Q3	$13K	Buy	+11,025	New	+$11.9K	﹤0.01%	1964
2022 Q2	–	Hold	0	–	–	–	2014
2018 Q4	–	Sell	-14,395	Closed	-$39K	–	2169
2018 Q3	$39K	Sell	14,395 -7,505	-34%	-$15.5K	﹤0.01%	2061
2018 Q2	$42K	Hold	21,900	–	–	﹤0.01%	2085
2018 Q1	$46K	Buy	+21,900	New	+$46.9K	﹤0.01%	1976

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Man Group's INFI Position: Q4 2022 in Review

Man Group sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2022, closing a stake of 11,025 shares — an estimated $13K sold.

Man Group first reported a position in INFI in Q1 2018 and held it in 4 quarters. The position peaked at $46K in Q1 2018. 68 funds tracked by Wall St. Rank hold INFI as of Q4 2022.

Man Group reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
Man Group sold 11,025 Infinity Pharmaceuticals, Inc. shares in Q4 2022, an estimated $13K.
Man Group first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2018 and held it in 4 quarters.
Man Group's Infinity Pharmaceuticals, Inc. position peaked at $46K in Q1 2018.
68 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2022.

Based on Man Group's 13F filing for Q4 2022, filed 14 Feb 2023.